EP3377484
Aðferðir til meðhöndlunar á heila- og mænusiggi með því að nota pýrimídín og pýridín efnasambönd með BTK-hindrunarvirkni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.11.2016EP published:
6.9.2023EP application number:
16805251.2
EP translation filed:
6.11.2023Grant published:
15.12.2023EPO information:
European Patent Register
Max expiry date:
15.11.2036Expiry date:
15.11.2026Next due date:
30.11.2026
Title in English:
METHODS FOR TREATING MULTIPLE SCLEROSIS USING PYRIMIDINE AND PYRIDINE COMPOUNDS WITH BTK INHIBITORY ACTIVITYLanguage of the patent:
English
Timeline
Today
16.11.2016EP application
6.9.2023EP Publication
6.11.2023Translation submitted
15.12.2023Registration published
15.11.2026Expires
Owner
Name:
Merck Patent GmbHAddress:
Frankfurter Strasse 250, 64293 Darmstadt, DE
Inventor
Name:
DELLOVADE, TammyAddress:
Carlisle, MA 01741, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562256199 PDate:
17.11.2015Country:
US
Classification
Categories:
C07D 403/12, C07D 401/14, C07D 405/14, C07D 413/14, A61K 31/4418, A61K 31/505, A61K 31/506, A61K 31/513, A61K 31/5377, A61K 31/55, C07D 401/04, C07D 403/14, C07D 413/12, C07D 495/04, A61P 25/28
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 9.11.2023
Expires: 15.11.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 9.11.2023
Expires: 15.11.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.10.2024
Expires: 15.11.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 11.11.2025
Expires: 15.11.2026
Payer: Árnason Faktor ehf.